The DFM briefly entered bear market territory on Monday, touching levels roughly 22% below its February peak before closing down 2.53% at c. 5.3k points as week three of the war in Iran grinds on.
The market gained 4.1% yesterday, leaving it down 9% year-to-date.
Real estate stocks — the index's heaviest weight and most conflict-exposed sector — have shed some 31% since the war began, dragging financials and transport with them. The pullback is a sharp reversal for an exchange that rallied c. 300% over six years on the back of Dubai's tourism, property, and financial services boom.
DFM is the worst-hit bourse in the region: The ADX is down c. 9.5% since the war started, while Tadawul has actually rallied more than 2%. “The decline appears to be less about panic selling and more about markets adjusting to higher short-term risk and slower activity in sectors that are central to Dubai's economy,” Christy Achkar, financial market analyst at CFI Dubai, tells us.
SIGN OF THE TIMES- Does Sumitomo Mitsui have the war yips? That’s the suggestion from Bloomberg, which notes that SMBC has taken the “unusual step” of asking Asian banks backing a USD 1.5 bn loan to Saudi Energy to confirm that they’re still on board. SMBC is sole underwriter on the facility, commitments for which are due by the end of this month.
Deals
India is reportedly shelving its sale of a majority stake in state-owned IDBI Bank, putting Emirates NBD’s biggest subcontinent play on ice and causing IDBI shares to drop as much as 16.5%, Reuters reports. The Dubai lender was competing against Canada’s Fairfax for a 60.7% slice valued north of USD 7.5 bn, but bids fell short of New Delhi’s expectations. Foreign appetite for Indian banking assets isn’t the problem — the government thinks both ENBD and Prem Watsa made low-ball offers, leaving Emirates NBD to bide its time on what would have been a landmark cross-border acquisition.
IHC greenlit another AED 5 bn share buyback, just three months after wrapping itsprevious buyback program and signaling it was done with repurchases, according to a bourse filing (pdf). The program covers c. 0.6% of total shares, with a two-year execution window. IHC could reduce its capital if the repurchased equity isn’t offloaded. It’s a simple message: IHC thinks its share is undervalued and wants to signal confidence even after the recent war-induced market plunge.
LVP Pharma has nearly doubled its stake in EGX-listed Rameda to 23.15%, acquiring 223 mn shares at c. EGP 5.1 apiece in a deal worth EGP 1.14 bn, according to a bourse filing (pdf). It’s the firm’s third major move on Rameda in just over a month. The roll-up comes as Egypt’s pharma sector faces rising pressure from higher import costs tied to the weaker EGP and shipping disruptions — production costs could climb as much as 30% over the next three months if FX pressures persist, the head of the pharma division at the Egyptian Chambers of Commerce told EnterpriseAM earlier this month.
Also worth knowing today-
Egypt is gearing up for a post-Eid privatization sprint, targeting USD 3-4 bn in inflows by year-end from at least 20 state-owned enterprise exits or IPOs — with the government favoring 10-40% public listings on the EGX over strategic sales, EnterpriseAM Egypt reports.
Amanat subsidiary Cambridge Health Group bought out remaining minority investors to take full ownership of Jeddah-based Sukoon International Holding, completing a decade-long consolidation that began with a 33.3% stake in 2015, according to a DFM disclosure (pdf). Transaction value undisclosed.
Cairo-based Hassan Allam’s SPAC has rebranded as Grova Venture Capital per an EGXdisclosure (pdf), raising authorized capital to EGP 500 mn with funds earmarked to finance acquisitions and inject liquidity into targets, per a separate filing (pdf).
Market Snapshot
Tadawul -0.3% • ADX +0.8% • DFM flat • EGX30 +1.2%
Brent USD 74.10 / bbl • Gold USD 2,038 / oz • USD / SAR 3.7502 • USD / EGP 50.85
Related